CERE Market Cap History



Below is a table of the CERE market cap history going back to 2/18/2022:

Date CERE Market Cap
2/18/20223.55B
5/2/20224.58B
10/28/20224.49B
2/10/20235.12B
4/28/20234.55B
7/28/20234.80B
10/27/20234.12B
2/15/20247.80B

Also see: CERE Shares Outstanding History
and CERE YTD Return
CERE Historical Market Cap:
+48.38% CAGR
CERE Historical Market Cap: +48.38% CAGR

Mouse over chart for data details
2/18/20225/2/202210/28/20222/10/20234/28/20237/28/202310/27/20232/15/2024
Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism. We show 8 historical shares outstanding datapoints in our CERE shares outstanding history coverage, used to compute CERE market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CERE market cap history over the course of time is important for investors interested in comparing CERE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CERE versus a peer is one thing; comparing CERE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CERE can fluctuate over the course of history. With this page we aim to empower investors researching CERE by allowing them to research the CERE market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CERE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cerevel Therapeutics Holdings (CERE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CERS Market Cap History
CFMS Market Cap History
CFRX Market Cap History
CGEM Market Cap History
CGEN Market Cap History
CGIX Market Cap History
CGTX Market Cap History
CHE Market Cap History
CHFS Market Cap History
CHMA Market Cap History
More Healthcare companies »

 

CERE Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.